Autopsy report · NCT01420666

Maxi-Analgesic Osteoarthritis (OA) Study

“The study was withdrawn for administrative reason”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 3

Sponsor

AFT Pharmaceuticals, Ltd.

Sponsor type

Industry

Conditions

Osteoarthritis

Interventions

Acetaminophen; Maxigesic 325; Ibuprofen; Placebo

Participants

0

Trials that died the same way

• Sym004 Versus TAS-102 in Patients With mCRC
  “Study was withdrawn due to administrative reasons” (97% match in meaning)
• Safety and Efficacy Study for Corneal Collagen Cross-Linking in Eyes With Corneal Ectasia After Refractive Surgery
  “This study was withdrawn for business reasons.” (87% match in meaning)
• Characteristic Analysis and Surgical Exploration for Acetabular Roof Fractures: Multicenter Retrospective Cohort Study
  “Due to limited funding, the study is now being withdrawn.” (85% match in meaning)
• A Study of MEK162 and AMG 479 in Patients With Selected Solid Tumors
  “Study was withdrawn due to scientific and business considerations.” (85% match in meaning)
• Sym004 Versus Futuximab or Modotuximab in Patients With mCRC
  “Study was terminated due to administrative reasons” (84% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.